Skip to main content
. 2023 Apr 17;16(4):100765. doi: 10.1016/j.waojou.2023.100765

Table 2.

Allergic manifestations in IgG4-RD.

Rhinitis Conjunctivitis Asthma Food allergy Drug allergy Anaphylaxis Others
Saeki 201836
22/51 (43%)
allergic conditions
15 (29%) 4 (8%) 16 (25%) – – – –
Sanders 202025
165/231 (71%) allergic conditions
Aero-allergens symptoms: 135 (58%) 47 (20%) – 20 (9%) Skin allergya:
927 (42%)
Zhou 202018
201/459 (44%) allergic diseases
99 (22%) – 20 (4%) 3 (1%) 30 (7%) – Contact allergy: 7 (2%)
Mixed allergies: 11 (6%)
“Irritable the physique”: 8 (2%)
Lin 201544
73/118 (62%) allergy
33 (28%) – 33 (28%) 6 (5%) 24 (20%) – Skin sensitivity or urticaria:
10 (8%)
Zen 201028
22/114 (19%) allergic disorders
Sinusitis:
4 (4%)
Rhinitis: (2%)
– 14 (12%) – 2 (2%) – –
Della Torre 201419
22/70 (31%) atopy
16 (23%) 5 (7%) 8 (11%) OAS: 1 (1%) – 0 (0%) Urticaria: 3 (4%)
Della-Torre 202050
29/116 (25%) atopy
14 (12%) 10 (9%) aeroallergen:
6 (5%)
food and drugs:
9 (8%)
3 (3%) 18 (16%) 3 (3%) Contact allergy: 3 (2%)
Urticaria/angioedema: 10 (9%)
Dermatitis: 6 (5%)
GI symptoms: 1 (1%)
Mattoo 201420
18/39 (46%) atopy
12 (31%) 3 (8%) 5 (13%) – – 0 (0%) Urticaria: 3 (8%)
GI symptoms: 1 (3%)
Mattoo 201621
33/74 (45%) atopy
18 (24%) 5 (7%) 9 (12%) OAS: 1 (1%) – 0 (0%) Urticaria: 3 (4%)
Eczema: 2 (6%)
“Hay fever”: 2 (6%)
Inoue 201553
–
29 (12%) – 25 (11%) – 16 (7%) – –
Matsui 201854
–
20 (30%) – 18 (27%) – – – Skin allergya: 9 (13%)
AIP
Hirano 201052
7/42 (16%) allergic conditions
3 (7%) – 3 (7%) – – – Urticaria: 1 (2%)
Kamisawa 200933
20/45 (44%)
allergic conditions
11 (24%) – 3 (7%) – 2 (4%) – Hypersensitivity pneumonitis: 1 (2%)
Sah 201034
12/78 (15%)
– – 9 (12%) – – – Others: 3 (4%)
Kuruma 201435
24/67 (36%)
15 (22%) – 8 (12%) 1 (2%) 4 (6%) – Atopic dermatitis: 2 (3%)
House dust allergy: 1 (2%)
Hamster allergy: 1 (2%)
DS
Yamamoto 201955
165/281 (59%) allergy
140 (50%) 56 (20%) 25 (9%) – – – Urticaria: 5 (2%)
Masaki 200956
–
26 (41%) – 9 (14%) – – – –
Li et al. 201557
–
22 (52%) – 6 (14%) – – – –
a

Otherwise non specified, GI, Gastro-intestinal; NR, Not reported; OAS, Oral allergen syndrome